R&D expense

Recent Articles

RELATED ARTICLES

  1. Clover Biopharmaceuticals posted a surge in first-half earnings after a $384 million grant for Covid vaccine development was belatedly folded into its accounts.
    With healthier finances, Clover Bio shifts to flu and RSV vaccines
    2197.HK
  2. Health Guard plans dual listing to fund HPV vaccine fight
  3. China’s mRNA pioneer Stemirna faces post-Covid reinvention test
  4. FAST NEWS: CanSino’s revenue plunges as demand dries up for Covid vaccines
    6185.HK 688185.SHG
  5. FAST NEWS: CanSino receives Gates Foundation grant to develop polio vaccine
    6185.HK 688185.SHG
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo File-alt

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva